Arkolith/Insider Trading/LIXT/Form 4

Primus Guy Warren

DirectorLIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) · full profile →Form 4 · filed Apr 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Grant(A)25K——25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 15, 2026Disposed to issuer(D)25K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-017854) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML